-->

Company Registry

N8 Medical Inc
Profile last edited on: 10/8/2019

Antimicrobial surface-protected medical devices: reduction of infection and related complications
Year Founded
N/A
First SBIR Year
2018
Latest SBIR Award
2018
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6000 Memorial Drive
Dublin, OH 43017
   (877) 686-3338
   N/A
   www.n8medical.com
Multiple Locations:   
Congressional District:   12
County:   Franklin

Public Profile

N8 Medical, LLC (N8 Medical) is a clinical-stage medical device company structured around development of medical devices that incorporate a novel class of active (proprietary) compounds called ceragenins - synthetic, non-peptide small molecule mimetics of endogenous host defense peptides. The public health and economic burden associated with device-related infections and other complications associated with medical devices factors to multi-billions of dollars. The proprietary ceragenin compounds utilized by N8 Medical - engaging the firm's CeraShiled (TM) technology - can impart unique properties to medical devices to include antimicrobial, anti-inflammatory and other therapeutic properties representing both a major business development opportuity and an important health benefit both in terms of improved patient outcomes and a likely lowering of theoverall cost of care. In Spring 2019, N8 announced the First-in-Human Use of its CeraShield™ Endotracheal Tube

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2018 1 NIH $200,000
A 3D Printed Resorbable Antimicrobial Envelope to Prevent Infection of Implanted Cardiac Devices

Key People / Management

  Ronald Bracken -- President and Chief Operating Officer

  Marc Rohman -- Chief Executive Officer

  Glenn Brunner -- VP, Product Development

  Carl Genberg -- Founder, Chief Scientific Officer Senior VP, R&D,